Indian Journal Watch: 25 October 2026

Indian Journal Watch, InfectionIndia.com

Indian Journal Watch

25 October 2026

Peer-reviewed microbiology, infectious disease, AMR and infection-control papers from India and South Asia, published or added to PubMed from 23 to 25 October 2026.

Lead articles

AMR · BMC Pediatrics

Geographic and genomic determinants of antimicrobial resistance in Indian children: a systematic review and meta-analysis

BMC Pediatrics · doi:10.1186/s12887-026-07389-y · PubMed 42919271

What
Magnitude and regional variation of antimicrobial resistance in bacterial isolates from children (≤18 years) in India, with genomic data on resistance determinants.
Design
Systematic review and meta-analysis following PRISMA 2020 and Joanna Briggs Institute guidelines. PubMed/MEDLINE, Scopus and the Cochrane Library were searched from inception to December 2025. Stratified random-effects meta-analyses were performed by geographic zone for key resistance phenotypes.
Key findings
Forty-seven studies met the inclusion criteria, of which 23 contributed to the quantitative synthesis. Carbapenem resistance among neonatal intensive care unit isolates ranged from 12% (95% CI 8-18) in Central India to 80% (70-88) in North India. Extended-spectrum β-lactamase production was 60-80% across most regions but 38% in Central India. MRSA prevalence ranged from 35% (26-44) to 61% (49-72). Fluoroquinolone resistance exceeded 85% in North, South and East/Northeast regions, whereas colistin resistance remained ≤8% nationally. Genomic data showed widespread dissemination of blaCTX-M-15 and regional clustering of carbapenemase genes (blaNDM, blaOXA).
Limitations
Only 2 to 8 studies contributed to each pooled estimate, and heterogeneity (I²) ranged from 19% to 79%, reflecting clinical and methodological differences across pathogens, antibiotic classes and settings.
Relevance to India
The authors report up to five-fold regional differences in carbapenem resistance among Indian children and conclude that the findings support region-specific empirical treatment guidelines, paediatric-focused antimicrobial stewardship and integrated phenotypic-genomic surveillance.

Tuberculosis · Indian Journal of Medical Research

Characterization of pyrazinamide resistance among presumptive multidrug-resistant tuberculosis cases by targeted sequencing

Indian Journal of Medical Research · doi:10.25259/ijmr_3572_2025

What
Prevalence of pyrazinamide (PZA) resistance among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in New Delhi, and its genotypic characterisation by targeted DNA sequencing.
Design
A total of 2,631 smear-positive, presumptive MDR-TB patients were tested by line probe assay (LPA). A subset of 534 samples (MDR/RR-TB, isoniazid-mono-resistant, and rifampicin- and isoniazid-sensitive by LPA) underwent MGIT culture and PZA drug susceptibility testing. PZA-resistant isolates (n=83) underwent targeted sequencing of resistance-associated genes. The study was led by the National Institute of Tuberculosis and Respiratory Diseases, New Delhi, with the Translational Health Science and Technology Institute, Faridabad.
Key findings
PZA resistance was 45.6% among RR-TB/MDR-TB isolates compared with 5% among rifampicin- and isoniazid-sensitive isolates, a significant association (P<0.001). On pncA sequencing, 72 isolates were mutant (10 carried the silent mutation S65S) and 3 were wild type. The 13 pncA wild-type and S65S isolates were also wild type for panD and rpsA.
Limitations
Some PZA-resistant isolates had no resistance-associated mutation in the three genes examined, and the authors state that further studies are needed on other genes that may be associated with PZA resistance.
Relevance to India
The authors conclude that the high frequency of PZA resistance underscores the need for routine PZA resistance testing, preferably by genotypic DST (targeted sequencing), which offers a short turnaround time.

More from the journals

Antimicrobial resistance & stewardship

Tuberculosis

Diagnostics

Virology

Vector-borne, zoonotic & NTDs

Other

Items are summaries of published abstracts and are not clinical advice. Readers should consult the original article. Figures are quoted as reported in each abstract.

Leave a Reply

Your email address will not be published. Required fields are marked *